Upload Avatar (500 x 500)
Yanxiang Cheng
Medical School
Wuhan University
Hubei
Language: English, Chinese
Pregnancy
Disease
Ovulation
Disorder
Gynecology
Tumor
Clinical Research
Surgery
Treatment
Pathogenesis
Areas of Focus
- Pregnancy-related diseases
- Ovulation disorders
- Gynecological tumors
Work Experience
- 2020/11-present: Professor/Chief Physician, Renmin Hospital of Wuhan University
- 2018/10-present: Director of Gynecology, East Hospital, Renmin Hospital of Wuhan University
- 2016/11-present: Chief Physician, Department of Gynecology and Obstetrics, Renmin Hospital of Wuhan University
- 2015/12-2016/12: Visiting Scholar, University of Pennsylvania, USA
- 2011/10-2016/10: Associate Chief Physician, Department of Gynecology and Obstetrics, Renmin Hospital of Wuhan University
- 2008/07-2011/09: Attending Physician, Department of Gynecology and Obstetrics, Renmin Hospital of Wuhan University
- 1998/07-2003/08: Resident and Attending Physician, Department of Gynecology and Obstetrics, First People's Hospital of Xiantao, Hubei
Academic Background & Achievements
- 2003-2008: PhD in Gynaecology and Obstetrics, Tongji Hospital, Huazhong University of Science and Technology
- 1993-1998: Bachelor in Clinical Medicine, Wuhan University Medical School
- Visiting Scholar at University of Pennsylvania, USA (2015-2016)
Publications
- Comparison of the different animal modeling and therapy methods of premature ovarian failure in animal model, Yanxiang Cheng et al., 2023
- Deletion of Insulin-like growth factor II mRNA-binding protein 3 participates in the pathogenesis of recurrent spontaneous abortion by inhibiting IL-10 secretion and inducing M1 polarization, Yanxiang Cheng et al., 2023
- MiR-93-5p promotes granulosa cell apoptosis and ferroptosis by the NF-kB signaling pathway in polycystic ovary syndrome, Yanxiang Cheng et al., 2022
- Irisin reduces the abnormal reproductive and metabolic phenotypes of PCOS by regulating the activity of brown adipose tissue in mice, Yanxiang Cheng et al., 2022
- The mechanism of Insulin-like growth factor II mRNA-binging protein 3 induce decidualization and maternal-fetal interface cross-talk by TGF-β1 in recurrent spontaneous abortion, Yanxiang Cheng et al., 2022
- Touchable cell biophysics property recognition platforms enable multifunctional blood smart health care, Yanxiang Cheng et al., 2021
- Microfluidic-based in vitro thrombosis model for studying microplastics toxicity, Yanxiang Cheng et al., 2022
- Application of synthetic and natural polymers in surgical mesh for pelvic floor reconstruction, Yanxiang Cheng et al., 2021
- Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis, Yanxiang Cheng et al., 2021
- Enhanced Cellular Compatibility of Chitosan/Collagen Multilayers LBL Modified Nanofibrous Mats, Yanxiang Cheng et al., 2021
- Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway, Yanxiang Cheng et al., 2021
- Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis, Yanxiang Cheng et al., 2021
- INO80 participates in the pathogenesis of recurrent miscarriage by epigenetically regulating trophoblast migration and invasion, Yanxiang Cheng et al., 2021
- LNK promotes granulosa cell apoptosis in PCOS via negatively regulating insulin-stimulated AKT-FOXO3 pathway, Yanxiang Cheng et al., 2020
- 3D printed intelligent scaffold prevents recurrence and distal metastasis of breast cancer, Yanxiang Cheng et al., 2020
- Carboxymethyl chitosan/sodium alginate-based micron-fibers fabricated by emulsion electrospinning for periosteal tissue engineering, Yanxiang Cheng et al., 2020
- Lysozyme/collagen multilayers layer-by-layer deposited nanofibers with enhanced biocompatibility and antibacterial activity, Yanxiang Cheng et al., 2020
- YY1-PVT1 affects trophoblast invasion and adhesion by regulating mTOR pathway-mediated autophagy, Yanxiang Cheng et al., 2020
Awards
- 2023: Second Prize, Hubei Province Science and Technology Progress Award, for 'Diagnosis and Treatment Strategies and Technological Innovations for Recurrent Pregnancy Failure'
- 2022: Core Talent Outstanding Contribution Award, Renmin Hospital of Wuhan University
- 2021: Core Talent Outstanding Contribution Award, Renmin Hospital of Wuhan University
- 2020: Core Talent Outstanding Contribution Award, Renmin Hospital of Wuhan University
- 2020: Advanced Individual in COVID-19 Epidemic Prevention, Chinese Association of Rehabilitation Medicine
- 2020: Anti-Epidemic Hero, Renmin Hospital of Wuhan University
- 2019: Third Prize, Hubei Province Science and Technology Progress Award, for 'Mechanism and Targeted Blockade of Common Gynecological Tumors'
- 2019: Advanced Worker, Renmin Hospital of Wuhan University
- 2018: Outstanding Medical Worker, Charity China Tour
- 2018: Outstanding Class Tutor, Wuhan University
- 2018: Outstanding Standardized Training Teacher, Renmin Hospital of Wuhan University
- 2018: Advanced Worker, Renmin Hospital of Wuhan University
- 2017: Hurun-Ping An Good Doctor of China Award
- 2016: Core Talent Award, Renmin Hospital of Wuhan University
- 2009: First Prize, Hubei Province Science and Technology Progress Award, for 'Research on the Pathogenesis and Surgical Treatment of Female Pelvic Floor Dysfunction'
